Cordyceps Sunshine Biotech Holdings Balance Sheet Health
Financial Health criteria checks 2/6
Cordyceps Sunshine Biotech Holdings has a total shareholder equity of $-78.7K and total debt of $445.3K, which brings its debt-to-equity ratio to -565.6%. Its total assets and total liabilities are $3.4M and $3.5M respectively. Cordyceps Sunshine Biotech Holdings's EBIT is $225.4K making its interest coverage ratio 8.5. It has cash and short-term investments of $15.3K.
Key information
-565.6%
Debt to equity ratio
US$445.28k
Debt
| Interest coverage ratio | 8.5x |
| Cash | US$15.28k |
| Equity | -US$78.73k |
| Total liabilities | US$3.50m |
| Total assets | US$3.42m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: RAJA.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: RAJA.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: RAJA.F has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: RAJA.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: RAJA.F's debt is well covered by operating cash flow (72.9%).
Interest Coverage: RAJA.F's interest payments on its debt are well covered by EBIT (8.5x coverage).